Xianying Chen

State Key Laboratory Of Virology And Biosafety
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.

Journal: Frontiers in cellular and infection microbiology

Published: August 22, 2025

Broadly Sarbecovirus-Neutralizing Antibodies Induced by Ancestral SARS-CoV-2 Infection.

Broadly Sarbecovirus-Neutralizing Antibodies Induced by Ancestral SARS-CoV-2 Infection.

Journal: Viruses

Published: August 21, 2025

A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.

A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression.

Journal: Virologica Sinica

Published: June 09, 2025

Clinical evaluation of a sensitive fluorescent PCR assay for trichomonas vaginalis.

Clinical evaluation of a sensitive fluorescent PCR assay for trichomonas vaginalis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: December 12, 2024

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.

Journal: Emerging microbes & infections

Published: May 16, 2024

SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.

SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.

Journal: The Journal of cell biology

Published: April 25, 2024

Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.

Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.

Journal: Virologica Sinica

Published: November 24, 2023

NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.

NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.

Journal: PLoS pathogens

Published: September 25, 2023

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.

Journal: Signal transduction and targeted therapy

Published: March 22, 2023

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.

Journal: Emerging microbes & infections

Published: January 21, 2022

Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China.

Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China.

Journal: Innovation (Cambridge (Mass.))

Published: September 02, 2021

Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.

Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice.

Journal: Emerging microbes & infections

Published: August 09, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026